These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37233811)

  • 21. Risks and overdose responses: Participant characteristics from the first seven years of a national take-home naloxone program.
    Ericson ØB; Eide D; Lobmaier P; Clausen T
    Drug Alcohol Depend; 2022 Nov; 240():109645. PubMed ID: 36191532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retrospective analysis of patterns of opioid overdose and interventions delivered at a tertiary hospital emergency department: impact of COVID-19.
    Potaka KL; Freeman R; Soo D; Nguyen NA; Sim TF; Moullin JC
    BMC Emerg Med; 2022 Apr; 22(1):62. PubMed ID: 35397487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Take-Home Naloxone and risk management from the perspective of people who survived an opioid overdose in Stockholm - An analysis informed by drug, set and setting.
    Holmén E; Hammarberg A; Kåberg M; Storbjörk J
    Int J Drug Policy; 2023 May; 115():104021. PubMed ID: 37011507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Naloxone and the Inner City Youth Experience (NICYE): a community-based participatory research study examining young people's perceptions of the BC take home naloxone program.
    Mitchell K; Durante SE; Pellatt K; Richardson CG; Mathias S; Buxton JA
    Harm Reduct J; 2017 Jun; 14(1):34. PubMed ID: 28592287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An overview of take-home naloxone programs in Australia.
    Dwyer R; Olsen A; Fowlie C; Gough C; van Beek I; Jauncey M; Lintzeris N; Oh G; Dicka J; Fry CL; Hayllar J; Lenton S
    Drug Alcohol Rev; 2018 May; 37(4):440-449. PubMed ID: 29744980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Injection Drug Use Frequency Before and After Take-Home Naloxone Training.
    Colledge-Frisby S; Rathnayake K; Nielsen S; Stoove M; Maher L; Agius PA; Higgs P; Dietze P
    JAMA Netw Open; 2023 Aug; 6(8):e2327319. PubMed ID: 37540514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acceptability of prison-based take-home naloxone programmes among a cohort of incarcerated men with a history of regular injecting drug use.
    Curtis M; Dietze P; Aitken C; Kirwan A; Kinner SA; Butler T; Stoové M
    Harm Reduct J; 2018 Sep; 15(1):48. PubMed ID: 30241532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does naloxone provision lead to increased substance use? A systematic review to assess if there is evidence of a 'moral hazard' associated with naloxone supply.
    Tse WC; Djordjevic F; Borja V; Picco L; Lam T; Olsen A; Larney S; Dietze P; Nielsen S
    Int J Drug Policy; 2022 Feb; 100():103513. PubMed ID: 34798434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Remaking the 'angry Narcanned subject': Affording new subject positions through take-home naloxone training.
    Ferguson N; Farrugia A; Moore D; Fraser S
    Int J Drug Policy; 2024 Jan; 123():104253. PubMed ID: 37995551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Take-Home Naloxone and the Need for a Publicly Funded Naloxone Supply.
    Kim HS; Aks SE
    J Addict Med; 2022 Jan-Feb 01; 16(1):1-3. PubMed ID: 33534277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors associated with take-home naloxone kit usage in British Columbia: an analysis of administrative data.
    Lei V; Ferguson M; Geiger R; Williams S; Liu L; Buxton JA
    Subst Abuse Treat Prev Policy; 2022 Mar; 17(1):25. PubMed ID: 35361228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opioid Overdose Prevention Programs Providing Naloxone to Laypersons - United States, 2014.
    Wheeler E; Jones TS; Gilbert MK; Davidson PJ;
    MMWR Morb Mortal Wkly Rep; 2015 Jun; 64(23):631-5. PubMed ID: 26086633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a take-home naloxone program at an urban academic emergency department.
    Eswaran V; Allen KC; Cruz DS; Lank PM; McCarthy DM; Kim HS
    J Am Pharm Assoc (2003); 2020; 60(6):e324-e331. PubMed ID: 32690447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sweden's first Take-Home Naloxone program: participant characteristics, dose endpoints and predictors for overdose reversals.
    Holmén E; Warnqvist A; Kåberg M
    Subst Abuse Treat Prev Policy; 2023 Apr; 18(1):24. PubMed ID: 37087485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploring the life-saving potential of naloxone: A systematic review and descriptive meta-analysis of take home naloxone (THN) programmes for opioid users.
    McAuley A; Aucott L; Matheson C
    Int J Drug Policy; 2015 Dec; 26(12):1183-8. PubMed ID: 26508033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alberta's provincial take-home naloxone program: A multi-sectoral and multi-jurisdictional response to overdose.
    Freeman LK; Bourque S; Etches N; Goodison K; O'Gorman C; Rittenbach K; Sikora CA; Yarema M
    Can J Public Health; 2017 Nov; 108(4):e398-e402. PubMed ID: 29120311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Who is using take-home naloxone? An examination of supersavers.
    Eide D; Lobmaier P; Clausen T
    Harm Reduct J; 2022 Jun; 19(1):65. PubMed ID: 35717240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A systematic review and meta-analysis of the prevalence of take-home naloxone (THN) ownership and carriage.
    Burton G; McAuley A; Schofield J; Yeung A; Matheson C; Parkes T
    Int J Drug Policy; 2021 Oct; 96():103298. PubMed ID: 34078563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Overdose Response with Take Home Naloxone (ORTHN) project: Evaluation of health worker training, attitudes and perceptions.
    Monds LA; Bravo M; Mills L; Malcolm A; Gilliver R; Wood W; Harrod ME; Read P; Nielsen S; Dietze PM; Lenton S; Bleeker AM; Lintzeris N
    Drug Alcohol Rev; 2022 Jul; 41(5):1085-1094. PubMed ID: 35442514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Training family members to manage heroin overdose and administer naloxone: randomized trial of effects on knowledge and attitudes.
    Williams AV; Marsden J; Strang J
    Addiction; 2014 Feb; 109(2):250-9. PubMed ID: 24103087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.